Business Context and Reporting Period
This Form 8-K is a current report filed by Sunshine Heart, Inc. (not Nuwellis, Inc.) on March 1, 2016. The filing discloses the appointment of John L. Erb as Chief Executive Officer and President, effective March 1, 2016. Mr. Erb continues to serve as Chairman of the Board. He previously served as Interim CEO and President since November 2015.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation and employment terms.
Material Changes
The primary material change is the formal appointment of John L. Erb as CEO and President, transitioning from his interim role. The company entered into a new Executive Employment Agreement with Mr. Erb on March 1, 2016.
Guidance, Outlook, and Compensation Details
The filing details the compensatory arrangements for the new CEO under the Executive Employment Agreement:
- Base Salary: At least $400,000 annually, subject to annual review.
- Equity Grants:
- Stock option for 534,000 shares of common stock.
- Grant of 356,000 restricted stock units (RSUs).
- Opportunity for additional annual equity awards based on performance.
- Performance Bonus: Up to 50% of the annual base salary based on Board-established goals.
- Term: Initial 12-month term with automatic renewal unless notice is given 90 days prior to expiration.
- Severance: In the event of termination without cause or for good reason, Mr. Erb is entitled to one times annual base salary, 12 months of continued medical coverage, 12 months of continued equity vesting, and a pro-rated annual bonus, subject to signing a release of claims.
- Recoupment: The agreement includes a clawback provision for unearned incentive compensation in cases of fraud, negligence, or intentional misconduct leading to financial restatements.
Investor Verification Checklist
- Verify the exact exercise price for the 534,000 stock options, which is tied to the closing sales price on the grant date.
- Review the specific performance goals established by the Board for the annual bonus calculation.
- Confirm the vesting schedule for the 356,000 RSUs and the 534,000 stock options as defined in the 2011 Equity Incentive Plan.
- Examine the definitions of "cause," "good reason," and "disability" within the full text of the Executive Employment Agreement (Exhibit 10.1).